Jerome Cambre - Jan 17, 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role
Vice President of Sales
Signature
/s/ Jesse Bergeron, Attorney-in-Fact
Stock symbol
VMD
Transactions as of
Jan 17, 2024
Transactions value $
-$61,097
Form type
4
Date filed
1/19/2024, 05:50 PM
Previous filing
May 11, 2023
Next filing
Jan 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VMD Common Shares Options Exercise +2.13K +3.23% 68K Jan 17, 2024 Direct F1
transaction VMD Common Shares Disposed to Issuer -$15.7K -2.13K -3.13% $7.39 65.9K Jan 17, 2024 Direct F2
transaction VMD Common Shares Options Exercise +8.53K +12.94% 74.4K Jan 17, 2024 Direct F3
transaction VMD Common Shares Tax liability -$22.5K -3.04K -4.09% $7.39 71.4K Jan 17, 2024 Direct F2, F4
transaction VMD Common Shares Options Exercise +3K +4.21% 74.4K Jan 18, 2024 Direct F1
transaction VMD Common Shares Disposed to Issuer -$22.9K -3K -4.04% $7.62 71.4K Jan 18, 2024 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VMD Phantom Share Units Options Exercise -2.13K -33.33% 4.26K Jan 17, 2024 Common Shares 2.13K Direct F1, F6
transaction VMD Restricted Stock Units Options Exercise $0 -8.53K -33.33% $0.00 17.1K Jan 17, 2024 Common Shares 8.53K Direct F3, F7
transaction VMD Phantom Share Units Options Exercise -3K -50% 3K Jan 18, 2024 Common Shares 3K Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2 Per share value is based on the market closing price of the common shares for January 17, 2024.
F3 Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F4 Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F5 Per share value is based on the market closing price of the common shares for January 18, 2024.
F6 Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7 Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F8 Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.